VERAVera Therapeutics, Inc.
32.29USD-3.27%Mkt Cap: 2.32B USDP/E:

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a ful…

Indicators:|

Key Statistics

Company
Market Cap2.32B USD
Enterprise Value1.80B USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-299.62M USD
Revenue/Share
Last Price32.29 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees339
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-8.49
PEG
EV/EBITDA-4.70
EV/Revenue
P/S
P/B4.64
EPS (TTM)-5.54
EPS (Forward)-3.80
52W Range
19.0736% of range56.05
52W High56.05 USD
52W Low19.07 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.56%
ROA-40.78%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-241.10M USD
CapEx (TTM)630.00K USD
FCF Margin
FCF Yield-7.74%
Net Debt-519.87M USD
Net Debt/EBITDA1.36
Balance Sheet
Debt/Equity0.13
Current Ratio13.64
Quick Ratio13.30
Book Value/Sh6.966 USD
Cash/Share8.313 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)78.00 USD
Target Range35.00 USD110.00 USD
# Analysts14
Ownership
Shares Out.71.78M
Float52.06M
Insiders0.88%
Institutions110.60%
Short Interest
Short Ratio9.8d
Short % Float15.99%
Short % Out.14.04%
Shares Short10.08M
Short (prev mo.)9.87M
Technical
SMA 5037.91 (-14.8%)
SMA 20036.56 (-11.7%)
Beta0.95
S&P 52W Chg27.18%
Avg Vol (30d)1.03M
Avg Vol (10d)957.01K
Technical Indicators
RSI (14)39.2
MACD-1.4083
MACD Signal-1.2809
MACD Hist.-0.1274
BB Upper39.31 USD
BB Middle34.92 USD
BB Lower30.52 USD
BB Width25.20%
ATR (14)2.228 USD
Vol Ratio (20d)1.60x